Primevax Immuno-Oncology has a total of 52 patents globally, out of which 10 have been granted. Of these 52 patents, more than 53% patents are active. The United States of America is where Primevax Immuno-Oncology has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Primevax Immuno-Oncology.
Primevax Immuno-Oncology was founded in 2015. Primevax Immuno-Oncology is working on a multi-mechanism cancer treatment that combines tailored neo-antigens with whole body systemic fever.
Do read about some of the most popular patents of Primevax Immuno-Oncology which have been covered by us in this article and also you can find Primevax Immuno-Oncology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Primevax Immuno-Oncology patent portfolio.
How many patents does Primevax Immuno-Oncology have?
Primevax Immuno-Oncology has a total of 52 patents globally. These patents belong to 5 unique patent families. Out of 52 patents, 28 patents are active.
How Many Patents did Primevax Immuno-Oncology File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Primevax Immuno-Oncology Applications Filed | Primevax Immuno-Oncology Patents Granted |
| 2022 | 1 | 2 |
| 2021 | 3 | 1 |
| 2020 | 5 | 2 |
| 2019 | 6 | 1 |
| 2018 | 15 | 1 |
| 2017 | 7 | 3 |
| 2016 | 15 | – |
How many Primevax Immuno-Oncology patents are Alive/Dead?
Worldwide Patents
How Many Patents did Primevax Immuno-Oncology File in Different Countries?
Countries in which Primevax Immuno-Oncology Filed Patents
| Country | Patent |
| United States Of America | 14 |
| Europe | 6 |
| Japan | 6 |
| Canada | 4 |
| China | 4 |
| Mexico | 3 |
| Hong Kong (S.A.R.) | 3 |
| Israel | 1 |
| Singapore | 1 |
| Australia | 1 |
| India | 1 |
| Austria | 1 |
| Germany | 1 |
| Korea (South) | 1 |
Where are Research Centers of Primevax Immuno-Oncology Patents Located?
The Research Centers of PrimevaxImmuno–Oncology Patents is the United States of America.
10 Best Primevax Immuno-Oncology Patents
WO2017004567A1 is the most popular patent in the Primevax Immuno-Oncology portfolio and it has received 15 citations.
Below is the list of 10 most cited patents of Primevax Immuno-Oncology:
| Publication Number | Citation Count |
| WO2017004567A1 | 15 |
| WO2017053873A1 | 10 |
| WO2018093907A1 | 7 |
| US9849167B2 | 6 |
| WO2018129202A1 | 6 |
| US9730989B2 | 5 |
| WO2018232166A1 | 5 |
| CN108291205A | 4 |
| CN110139671A | 3 |
| US10159727B2 | 2 |
What are Primevax Immuno-Oncology key innovation segments?
What Technologies are Covered by Primevax Immuno-Oncology?
The chart below distributes patents filed by Primevax Immuno-Oncology